Impact of textbook outcome after hepatectomy for colorectal metastases on salvage curative-intent treatment at recurrence

doi:10.4251/wjgo.v18.i7.120704

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 7

This Article

(23)

(18)

(0)

(22)

(372)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastrointest Oncol. Jul 15, 2026; 18(7): 120704
Published online Jul 15, 2026. doi: 10.4251/wjgo.v18.i7.120704

Table 1 Demographics and baseline characteristics, n (%)/mean ± SD/median (interquartile range)

Variables	Total (n = 204)	Non-TO (n = 63)	TO (n = 141)	P value
Gender				0.945
Female	77 (37.75)	24 (38.10)	53 (37.59)
Male	127 (62.25)	39 (61.90)	88 (62.41)
Age, years	58.62 ± 10.43	59.21 ± 10.80	58.36 ± 10.29	0.594
BMI, kg/m²	23.46 ± 3.29	22.96 ± 3.13	23.68 ± 3.34	0.147
Hypertension				0.135
No	127 (62.25)	44 (69.84)	83 (58.87)
Yes	77 (37.75)	19 (30.16)	58 (41.13)
Diabetes				0.597
No	181 (88.73)	57 (90.48)	124 (87.94)
Yes	23 (11.27)	6 (9.52)	17 (12.06)
ASA class				0.945
ASA class I-II	185 (90.69)	57 (90.48)	128 (90.78)
ASA class III	19 (9.31)	6 (9.52)	13 (9.22)
Colorectal cancer
Primary tumor location				0.211
Rectum	91 (44.61)	24 (38.10)	67 (47.52)
Colon	113 (55.39)	39 (61.90)	74 (52.48)
Lymph nodal metastasis				0.957
No	61 (29.90)	19 (30.16)	42 (29.79)
Yes	143 (70.10)	44 (69.84)	99 (70.21)
Tumor grade				0.306
Low	52 (25.49)	19 (30.16)	33 (23.40)
High	152 (74.51)	44 (69.84)	108 (76.60)
CRLM
Surgical approach				< 0.001
Open	53 (25.98)	30 (47.62)	23 (16.31)
Laparoscopic	151 (74.02)	33 (52.38)	118 (83.69)
Major hepatectomy
No	186 (91.18)	53 (84.13)	133 (94.33)	0.018
Yes	18 (8.82)	10 (15.87)	8 (5.67)
Synchronous¹				0.012
No	60 (29.41)	11 (17.46)	49 (34.75)
Yes	144 (70.59)	52 (82.54)	92 (65.25)
Distribution				0.844
Unilobar	134 (65.69)	42 (66.67)	92 (65.25)
Bilobar	70 (34.31)	21 (33.33)	49 (34.75)
Simultaneous colorectal resection				< 0.001
No	140 (68.63)	29 (46.03)	111 (78.72)
Yes	64 (31.37)	34 (53.97)	30 (21.28)
Number of lesions	2.00 (1.00, 3.00)	2.00 (1.00, 3.00)	2.00 (1.00, 3.00)	0.762
Max diameter, cm	2.80 (1.95, 4.00)	3.50 (2.20, 4.90)	2.50 (1.60, 3.50)	0.003
CEA, ng/mL	7.89 (3.51, 31.01)	8.82 (3.54, 29.12)	7.89 (3.53, 32.41)	0.429
Adjuvant therapy				0.963
No	49 (24.02)	15 (23.81)	34 (24.11)
Yes	155 (75.98)	48 (76.19)	107 (75.89)
Neoadjuvant therapy				0.005
No	103 (50.49)	41 (65.08)	62 (43.97)
Yes	101 (49.51)	22 (34.92)	79 (56.03)

¹Yes indicates synchronous metastasis, no indicates metachronous metastasis.

TO: Textbook outcome; BMI: Body mass index; ASA: American Society of Anesthesiologists physical status; CRLM: Colorectal liver metastases; CEA: Carcinoembryonic antigen.

Full Size Table

Citation: Chen L, Song HC, Meng FZ, Zhang SY, An ZY, Ling XY, Zhang C, Zhu XC, Wang JZ, Song RP, Liu LX. Impact of textbook outcome after hepatectomy for colorectal metastases on salvage curative-intent treatment at recurrence. World J Gastrointest Oncol 2026; 18(7): 120704
URL: https://www.wjgnet.com/1948-5204/full/v18/i7/120704.htm
DOI: https://dx.doi.org/10.4251/wjgo.v18.i7.120704

Chen L, Song HC, Meng FZ, Zhang SY, An ZY, Ling XY, Zhang C, Zhu XC, Wang JZ, Song RP, Liu LX. Impact of textbook outcome after hepatectomy for colorectal metastases on salvage curative-intent treatment at recurrence. World J Gastrointest Oncol 2026; 18(7): 120704 [DOI: 10.4251/wjgo.v18.i7.120704]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.